AXQ Capital
INMB icon

AXQ Capital’s INmune Bio INMB Stock Holding History

AXQ Capital’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$81.7K Buy
+41,909
New +$86.2K 0.01% 910

Other funds holding INMB

Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Westside Investment Management
Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Focus Partners Advisor Solutions
Focus Partners Advisor Solutions Saint Louis, Missouri $12.4B AUM 18.32% 1-Year Est. Return

AXQ Capital's INMB Position: Q3 2026 in Review

AXQ Capital opened a new position in INmune Bio (INMB) in Q3 2026: 41,909 shares worth $81.7K. The stake represents 0.01% of the portfolio and ranks #910 among its holdings.

37 funds tracked by Wall St. Rank hold INMB as of Q3 2026.

  • AXQ Capital held 41,909 shares of INmune Bio worth $81.7K as of Q3 2026.
  • INmune Bio was a new AXQ Capital position in Q3 2026.
  • INmune Bio made up 0.01% of AXQ Capital's portfolio in Q3 2026, its #910 holding.
  • 37 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.

Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.